Oxiracetam

奥拉西坦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxiracetam
Drug Alias Name奥拉酰胺oxiracetamum奥希拉坦欧来宁欧兰同 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIschemiaTrichothiodystrophy SyndromesMemory Disorders +[6] 
Global Approved IndicationsMemory DisordersDementiaBrain Injuries
Approved Indications in ChinaMemory DisordersDementiaBrain Injuries
Original Approved Country/TerritoryItaly
Original Approved Date1987/01/01
Country/TerritoryPortugalItalySouth Korea +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Dongze Medicine Technology Development Co LtdCspc Ouyi Pharmaceutical Co LtdHunan Jianlang Pharmaceutical Industry Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsIschemiaTrichothiodystrophy SyndromesMemory Disorders +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN06BX07
Related LinksWikipediaKEGG